Franco D. Doimi

RAS/MAPK Activation Is Associated with Reduced Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer: Therapeutic Cooperation Between MEK and PD-1/PD-L1 Immune Checkpoint Inhibitors

Sherene Loi, Sathana Dushyanthen, Paul A. Beavis et al. · Clinical Cancer Research · 2015 · 552 citations · Full text

Medicine, Immunology, Oncology +17

Molecular Profiling of the Residual Disease of Triple-Negative Breast Cancers after Neoadjuvant Chemotherapy Identifies Actionable Therapeutic Targets

Justin M. Balko, Jennifer M. Giltnane, Kai Wang et al. · Cancer Discovery · 2013 · 477 citations · Full text

Medicine, Cancer Biology, Oncology +17

Evaluation of a 30-Gene Paclitaxel, Fluorouracil, Doxorubicin, and Cyclophosphamide Chemotherapy Response Predictor in a Multicenter Randomized Trial in Breast Cancer

Adel Tabchy, Vicente Valero, Tatiana Vidaurre et al. · Clinical Cancer Research · 2010 · 212 citations · Full text

Medicine, Oncology, Pharmacology +15

Triple-negative breast cancers with amplification of JAK2 at the 9p24 locus demonstrate JAK2-specific dependence

Justin M. Balko, Luis J. Schwarz, Na Luo et al. · Science Translational Medicine · 2016 · 135 citations · Full text

Medicine, Cancer Biology, Oncology +12

Effect of CCL5 expression in the recruitment of immune cells in triple negative breast cancer

Jhajaira M. Araujo, Andrea C. Gómez, Alfredo Aguilar et al. · Scientific Reports · 2018 · 107 citations · Full text

Medicine, Immunology, Oncology +15